Otonomy (NASDAQ:OTIC) Research Coverage Started at StockNews.com
Research analysts at StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report issued to clients and investors on Monday. The firm set a "hold" rating on the
Otonomy (NASDAQ:OTIC) Now Covered by StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a note issued to investors on Wednesday. The firm set a "hold" rating on the biopharmace
Olema Pharmaceuticals (NASDAQ:OLMA) and Otonomy (NASDAQ:OTIC) Critical Comparison
Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) and Otonomy (NASDAQ:OTIC – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based
Requisite Capital Management LLC Acquires Shares of 150,000 Otonomy, Inc. (NASDAQ:OTIC)
Requisite Capital Management LLC acquired a new stake in Otonomy, Inc. (NASDAQ:OTIC – Get Rating) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Ex
StockNews.com Initiates Coverage on Otonomy (NASDAQ:OTIC)
StockNews.com began coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the biopharmaceutical company'
Otonomy (NASDAQ:OTIC) Stock Passes Below 200-Day Moving Average of $0.32
Otonomy, Inc. (NASDAQ:OTIC – Get Rating)'s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.32 and traded as low as $0.1
Otonomy (NASDAQ:OTIC) Receives New Coverage From Analysts at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research note issued on Thursday. The brokerage set a "hold" rating on the biopharmaceutical
Otonomy (NASDAQ:OTIC) & Bio-Path (NASDAQ:BPTH) Financial Comparison
Otonomy (NASDAQ:OTIC – Get Rating) and Bio-Path (NASDAQ:BPTH – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the streng
Otonomy (NASDAQ:OTIC) Share Price Crosses Above 50-Day Moving Average of $0.11
Otonomy, Inc. (NASDAQ:OTIC – Get Rating) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.11 and traded as high as $0.13. Otonomy shares
Head-To-Head Review: Bio-Path (NASDAQ:BPTH) Versus Otonomy (NASDAQ:OTIC)
Bio-Path (NASDAQ:BPTH – Get Rating) and Otonomy (NASDAQ:OTIC – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the streng
StockNews.com Begins Coverage on Otonomy (NASDAQ:OTIC)
Analysts at StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research note issued to investors on Tuesday. The firm set a "hold" rating on the biopharmaceutical com
Otonomy (NASDAQ:OTIC) Coverage Initiated by Analysts at StockNews.com
Analysts at StockNews.com began coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research note issued to investors on Monday. The brokerage set a "hold" rating on the biopharmaceutical c
Elk Capital Makes Investment in Otonomy
Delisting of Securities of Tuscan Holdings Corp. II; Clovis Oncology, Inc.; ZyVersa Therapeutics, Inc.; Otonomy, Inc., and Forward Pharma A/S From The Nasdaq Stock Market
NEW YORK, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, unit, and warrant of Tuscan Holdings Corp. II. Tuscan Holdings Corp. II's securities were
Otonomy (NASDAQ:OTIC) Coverage Initiated at StockNews.com
StockNews.com initiated coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report sent to investors on Saturday. The brokerage issued a hold rating on the biopharmaceutical compan
Otonomy (NASDAQ:OTIC) Earns Hold Rating From Analysts at StockNews.com
StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the biopharmaceutical compa
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersImmuron (NASDAQ:IMRN) stock rose 42.9% to $2.3 during Monday's pre-market session. The market value of their outstanding shares is at $13.0 million. DBV Technologies (NASDAQ:DBVT) shares moved
Otonomy (NASDAQ:OTIC) Now Covered by Analysts at StockNews.com
Investment analysts at StockNews.com initiated coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a report issued on Saturday. The brokerage set a "hold" rating on the biopharmaceutical comp
12 Health Care Stocks Moving In Friday's Intraday Session
GainersImmuron (NASDAQ:IMRN) shares increased by 37.9% to $2.22 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 17.1 million shares, making up 288523.4% of it
Stocks That Hit 52-Week Lows On Friday
 OnFriday, 143 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Tesla (NASDAQ:TSLA).The smallest company in
No Data